BMO Capital analyst Jim Birchenough reiterated a Market Perform rating and bumped his price target on Amgen (NASDAQ: AMGN) to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE